Navigation Links
Study: Women with hard to diagnose chest pain symptoms at higher risk for cardiovascular events
Date:5/11/2009

LOS ANGELES (EMBARGOED UNTIL MAY 11, 2009; 3 pm Central Daylight Time) Many physicians are presented with the following scenario: a woman comes into the office complaining of chest pain, undergoes a stress test to evaluate the chest pain, and the stress test results suggest coronary artery disease, a condition in which plaque builds up inside the coronary arteries. She is then referred for an angiogram to look at the coronary arteries and despite her symptoms and the abnormal stress test, she is told that the tests didn't find anything of clinical significance and is sent home without treatment. However, a new study may change this by offering greater insight into the causes behind chest pain in women and how it manifests differently in women than it does in men. The study, published in the May 11 Archives of Internal Medicine, shows that women with chest pain but without coronary artery disease are at an elevated risk for cardiovascular events such as heart attack or stroke.

"These results combined with prior work suggest that women are not just smaller versions of men when it comes to heart disease," said C. Noel Bairey Merz, MD, director of the Women's Heart Center at the Cedars-Sinai Heart Institute and the chair of the Women's Ischemia Syndrome Evaluation (WISE). Sponsored by the National Heart Lung and Blood Institute, the WISE studies began in 1997 and have pointed out how differently men and women experience symptoms of coronary heart disease. "Women and men experience heart disease differently and require different treatments," added Bairey Merz.

"Our findings challenge the accepted belief in the medical community that these patients should be considered low-risk, and points towards the need for a different treatment regimen for these patients moving forward," said Martha Gulati, MD, first author of the study, cardiologist and associate director of the Center for Women's Cardiovascular Health at Northwestern Memorial's B
'/>"/>

Contact: Sally Stewart
Sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. 30-year follow-up study: Tremendous impact of smoking on mortality and cardiovascular disease
2. Study: Vibration plate machines may aid weight loss and trim abdominal fat
3. Study: Furniture tip-over injuries rising
4. Hopkins Childrens study: Folic acid may help treat allergies, asthma
5. Study: Lizards bask for more than warmth
6. National Physicians Study: Nearly One Third Would Choose Different Career Today
7. Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling
8. Study: Every 1.7 minutes a Medicare beneficiary experiences a patient safety event
9. Study: Doctor-patient conversations at end of life associated with lower medical expenses
10. UCF study: Hyperactivity enables children with ADHD to stay alert
11. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 /PRNewswire-Fi...s, Ltd (NYSE: AWH ) today announced that Scott C...nd Jack Sennott, Executive Vice,President and Chie...t the 2009,Goldman Sachs U.S. Financial Services C...ce Center in New York City on Tuesday, December 8,...
(Date:12/4/2009)..., KANSAS CITY, Mo., Dec. 4 The ... National Association of Free Clinics (NAFC) in Ka...r the sick but also for anyone who is uninsured an... in the health clinic will receive preventive prim...ee previous large free clinic events this fall in ...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -...m would control health care costs, Leapfrog,s purc...ugh example -- delivering the best quality care in...efficiency. Thirty-four urban, eight children,s an...rog Top Hospitals, based on results from The Leapf...
(Date:12/4/2009)... STANFORD, Calif. A new study shows that muscle ...ability to squeeze shut properly. The work, perfor...patients with conditions such as gastric reflux an...ed to strengthen sphincters, which are the bands o...intestinal tract. Weakness in these areas can caus...
(Date:12/4/2009)... than 15 million Americans are recruited annually ... Alliance for Human Research Protection (AHRP), an.... , Research institutions view payments to v...ot as compensation for potential risks related to ... finds that volunteers have a very different view ...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
...nologies Inc., a,leading developer and manufacture...today announced that the company has entered into ... with LightLab imaging.,Under this multi- year exc... system., (Photo: http://www.newscom.com/cgi-bin...
.... (San Francisco, CA,and Ottawa, Canada), announce...delivered a plenary session presentation on Friday... with JX-594, a Novel Targeted,Multi-Mechanistic O...his abstract was selected for presentation in the,...
...ata Demonstrating Superiority of XIENCE ...KYO, June 2 Abbott (NYSE: ABT ) today,announced ...bai Shonin,(Marketing Authorization License) to Ja...s Eluting Coronary Stent System to,treat coronary ...
...(OTC,Bulletin Board: IAGX) announced today that it...aVie LLC (http://www.monavie.com ) that provides ... Celadrin, a cellular lubricant, is a joint healt...ty.,Celadrin is a unique, scientifically arranged ...
...k II anaerobic,system for the cultivation of anaer... an excellent alternative to the use of anaerobic ...aboratories. The Anoxomat Mark II,automatic jar ev...the way the Anoxomat jar works, I can open it up, ...
..., kept tumors stable for almost 6 months , ...n therapy of gemcitabine, capecitabine and bevaciz...ancreatic cancer, according to a multi-center stud...ated by patients, was able to prevent tumors from ...
Other Medicine News:Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 3
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstC...), a leading global specialty pharmaceutical compa...boratories, Inc.-Florida, filed an Abbreviated New...ug Administration seeking approval to market its 8...patent owned by Takeda Pharmaceutical Company Limi...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCa...that the US Food and Drug Administration (FDA) has... fumarate) Extended Release Tablets as adjunctive ...th Major Depressive Disorder (MDD). SEROQUEL XR is...FDA to treat both major depressive disorder as adj...
(Date:12/3/2009)... , ALISO VIEJO, Calif. and STATE COLLEGE, Pa.,...etics today announced the signing of an agreement ...es using SoftGenetics, NextGENe software for next-... ,, (Logo: http://www.newscom.com/cgi-bin/p...PhD, Ambry,s CSO said, "Our team at Ambry has been...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3
Complete brand Blink-N-Clean Lens Drops
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
Medicine Products: